Dumont & Blake Investment Advisors LLC Invests $1.41 Million in Marsh & McLennan Companies, Inc. $MRSH

Dumont & Blake Investment Advisors LLC acquired a new position in Marsh & McLennan Companies, Inc. (NYSE:MRSH) during the first quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm acquired 8,098 shares of the financial services provider’s stock, valued at approximately $1,405,000.

Several other institutional investors have also added to or reduced their stakes in the business. Numerai GP LLC increased its stake in shares of Marsh & McLennan Companies by 966.2% in the third quarter. Numerai GP LLC now owns 37,220 shares of the financial services provider’s stock worth $7,501,000 after purchasing an additional 33,729 shares in the last quarter. Swiss Life Asset Management Ltd lifted its stake in shares of Marsh & McLennan Companies by 9.5% during the 4th quarter. Swiss Life Asset Management Ltd now owns 134,542 shares of the financial services provider’s stock valued at $24,960,000 after buying an additional 11,648 shares in the last quarter. Sarasin & Partners LLP boosted its holdings in Marsh & McLennan Companies by 0.9% in the 4th quarter. Sarasin & Partners LLP now owns 934,732 shares of the financial services provider’s stock worth $173,411,000 after buying an additional 8,283 shares during the period. CSM Advisors LLC purchased a new stake in Marsh & McLennan Companies in the 3rd quarter worth $1,180,000. Finally, Brown Brothers Harriman & Co. raised its holdings in Marsh & McLennan Companies by 26.4% during the third quarter. Brown Brothers Harriman & Co. now owns 136,179 shares of the financial services provider’s stock valued at $27,444,000 after acquiring an additional 28,419 shares during the period. 87.99% of the stock is currently owned by institutional investors.

Insider Buying and Selling at Marsh & McLennan Companies

In other news, CEO John Q. Doyle sold 16,656 shares of the business’s stock in a transaction dated Tuesday, June 2nd. The shares were sold at an average price of $161.71, for a total value of $2,693,441.76. Following the sale, the chief executive officer directly owned 116,811 shares in the company, valued at $18,889,506.81. The trade was a 12.48% decrease in their position. The transaction was disclosed in a filing with the SEC, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.38% of the stock is currently owned by company insiders.

Marsh & McLennan Companies Stock Down 2.2%

Shares of MRSH opened at $174.57 on Tuesday. The company has a debt-to-equity ratio of 1.28, a quick ratio of 1.11 and a current ratio of 1.11. The company has a market cap of $84.33 billion, a PE ratio of 21.82, a PEG ratio of 2.60 and a beta of 0.61. Marsh & McLennan Companies, Inc. has a 1 year low of $156.60 and a 1 year high of $216.32.

Marsh & McLennan Companies (NYSE:MRSH) last posted its earnings results on Thursday, April 16th. The financial services provider reported $3.29 earnings per share for the quarter, beating analysts’ consensus estimates of $3.21 by $0.08. The firm had revenue of $7.30 billion during the quarter. Marsh & McLennan Companies had a net margin of 14.26% and a return on equity of 31.87%. Marsh & McLennan Companies’s revenue was up 7.6% compared to the same quarter last year. Research analysts predict that Marsh & McLennan Companies, Inc. will post 10.38 EPS for the current fiscal year.

Analyst Ratings Changes

A number of equities analysts have recently weighed in on the company. Mizuho dropped their price objective on Marsh & McLennan Companies from $199.00 to $193.00 and set a “neutral” rating for the company in a research note on Monday, April 13th. Bank of America lowered their price target on Marsh & McLennan Companies from $181.00 to $174.00 and set an “underperform” rating on the stock in a report on Tuesday, April 14th. Barclays cut their price objective on shares of Marsh & McLennan Companies from $209.00 to $206.00 and set an “overweight” rating for the company in a report on Wednesday, April 8th. Keefe, Bruyette & Woods lifted their price objective on shares of Marsh & McLennan Companies from $200.00 to $203.00 and gave the company a “market perform” rating in a research report on Friday, April 17th. Finally, Morgan Stanley lowered their target price on shares of Marsh & McLennan Companies from $180.00 to $175.00 and set an “equal weight” rating on the stock in a report on Monday. One analyst has rated the stock with a Strong Buy rating, six have assigned a Buy rating, ten have assigned a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, the company has an average rating of “Hold” and an average price target of $199.25.

About Marsh & McLennan Companies

Marsh & McLennan Companies (NYSE: MMC) is a global professional services firm headquartered in New York City that provides advice and solutions in the areas of risk, strategy and people. Founded in 1905, the company has grown into a diversified group of businesses focused on insurance brokerage and risk management, reinsurance, human capital and investment consulting, and management consulting. Its long history and scale position it as a prominent adviser to corporations, governments and other institutions seeking to manage risk and optimize human and financial capital.

The firm operates through several well-known subsidiaries and business units that specialize in distinct services.